MDD VIDEOS & PRESENTATIONS

Stephen M. Stahl, MD, PhD

discusses current insights into the neurobiology of mood, reward, and emotion

Stephen M. Stahl, MD, PhD

discusses current insights into the neurobiology of mood, reward, and emotion

MECHANISMS OF MDD

Learn about the potential role of the endogenous opioid system in MDD.

Stephen M. Stahl, MD, PhD

Current Insights Into the Neurobiology of Mood, Reward, and Emotion and the Impacts on Unmet Needs in MDD

Larry Culpepper, MD, MPH,

discusses treatment goals for patients with MDD.

Andrew J. Cutler, MD,

discusses going beyond the current pathways to deepen our understanding of MDD.

Jon-Kar Zubieta, MD, PhD,

discusses the potential role of the endogenous opioid system in MDD.

A patient discusses

the real-world, daily struggles of living with depression.

MECHANISMS OF MDD Learn about the potential role of the endogenous opioid system in MDD.

Stephen M. Stahl, MD, PhD Current Insights Into the Neurobiology of Mood, Reward, and Emotion and the Impacts on Unmet Needs in MDD

Larry Culpepper, MD, MPH, discusses treatment goals for patients with MDD.

Andrew J. Cutler, MD, discusses going beyond the current pathways to deepen our understanding of MDD.

Jon-Kar Zubieta, MD, PhD, discusses the potential role of the endogenous opioid system in MDD.

A patient discusses the real-world, daily struggles of living with depression.

DOWNLOADABLE PRESENTATION

2019 PSYCHIATRY CONFERENCES: MAJOR DEPRESSIVE DISORDER:
LOOKING BEYOND MONOAMINES
VIEW PDF DOWNLOAD PRESENTATION

2019 CALENDAR OF EVENTS

Advance your understanding of approaches and pathways in MDD with presentations from leading experts in the treatment of depression.

Andrew J. Cutler, MD

  • May 21, 2019
  • APA Annual Conference
  • San Francisco, CA

Gustavo Alva, MD, DFAPA

  • November 10, 2019
  • NEI Annual Conference
  • Colorado Springs, CO
close
 
close
 
close
 
close
 
close
close
close
close
 

Thank you for your response.
An email reminder will be sent to you prior to the event.
To learn more about MDD targets beyond the monoamine pathway,

Visit ChallengeMDD.com

Thank you for your response.
To learn more about MDD targets beyond the monoamine pathway,

Visit ChallengeMDD.com

close

Sign Up for E-mail Updates

Submit your e-mail address to receive notifications about updates to this website and announcements and information from Alkermes about major depressive disorder (MDD).


Please enter your first name.

Please enter your last name.

Please enter a valid e-mail address.

Please enter a valid zip code.

Please enter a valid specialty.
Please check the box if you want to proceed.

*Required field.

Thank you!

close

Share information about challenges in
MDD patient management

*Please include a valid e-mail address.
*Please include a valid e-mail address.

*Required field.

close

Help us create a better, more informed experience for you.

Please answer these 2 questions to help shape this site for you and your peers. Your answers will remain anonymous:

Has the information on this page given you insight into how the modulation of the endogenous opioid system could lead to an antidepressant effect?

Help us create a better, more informed experience for you.

Please answer these 2 questions to help shape this site for you and your peers. Your answers will remain anonymous:

Was this information consistent with what you expected to learn here?

Thank you!